End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 CNY | +1.05% | -3.52% | +3.23% |
Apr. 15 | Kangmei Pharmaceutical Returns to Profit in 2023; Shares Decline 4% | MT |
Apr. 12 | Kangmei Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 4.18B 577M | Sales 2023 | 4.87B 673M | Capitalization | 25.79B 3.56B |
---|---|---|---|---|---|
Net income 2022 | -2.69B -371M | Net income 2023 | 103M 14.22M | EV / Sales 2022 | 7 x |
Net cash position 2022 | 1.24B 172M | Net cash position 2023 | 802M 111M | EV / Sales 2023 | 5.13 x |
P/E ratio 2022 |
-11.6
x | P/E ratio 2023 |
186
x | Employees | 4,409 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.44% |
1 day | +1.05% | ||
1 week | -3.52% | ||
Current month | -11.52% | ||
1 month | -13.90% | ||
3 months | +1.59% | ||
6 months | +1.59% | ||
Current year | +3.23% |
Managers | Title | Age | Since |
---|---|---|---|
Guo Wei Liu
CEO | Chief Executive Officer | 51 | 20-10-09 |
Gui Bo Gong
DFI | Director of Finance/CFO | 50 | 20-10-09 |
Min Li
IRC | Investor Relations Contact | 35 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Ping Lai
BRD | Director/Board Member | 63 | 20-10-29 |
Yan Zhu Gao
CHM | Chairman | 59 | 20-10-29 |
Qi Mi
BRD | Director/Board Member | 62 | 22-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 2,808 M€ | +4.06% | - | |
0.00% | 441 M€ | +2.75% | - | |
0.00% | 149 M€ | -0.66% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 1.92 | +1.05% | 77 977 420 |
24-04-22 | 1.9 | -0.52% | 68,141,810 |
24-04-19 | 1.91 | -0.52% | 79,264,290 |
24-04-18 | 1.92 | 0.00% | 78,029,760 |
24-04-17 | 1.92 | +1.59% | 117,890,400 |
End-of-day quote Shanghai S.E., April 22, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.23% | 3.64B | |
+27.89% | 659B | |
+27.68% | 557B | |
-4.43% | 359B | |
+16.40% | 322B | |
+9.32% | 297B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.60% | 149B |
- Stock Market
- Equities
- 600518 Stock